跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gencivenz-200 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gencivenz-200
Approved
STANDARD
Gencivenz-200
Shilpa Medicare Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
2a80a4ee3d104055
Company
Shilpa Medicare Limited
Type
Standard
Approval Details
Approval Id
2a80a4ee3d104055
Drug Approval Philippines Name
Gencivenz-200
Product Name
Gencivenz-200
Registration Number
DRP-10643
Brand Name
Gencivenz-200
Generic Name
Gemcitabine (as Hydrochloride)
Dosage Form
Lyophilized Powder For Injection (IV Infusion)
Dosage Strength
200 mg
Manufacturer
Shilpa Medicare Limited
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Company Detail Path
/organization/shilpa-medicare-limited
Issuance Date
26 October 2021
Expiry Date
26 October 2026
Pharmacologic Category
Antineoplastic (Pyrimidine Analogue)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
2a80a4ee3d104055
Type
Standard
Back to Philippines FDA Approvals